Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Oncolytics Biotech Inc (ONCY)

2.77   0.2 (7.78%) 11-29 20:35
Open: 2.7 Pre. Close: 2.57
High: 2.87 Low: 2.65
Volume: 1,008,455 Market Cap: 120M
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. The company is headquartered in Calgary, Alberta and currently employs 30 full-time employees. The firm is focused on the development of REOLYSIN, its cancer therapeutic. The firm's clinical program is made up of a registration program that includes muscle-invasive bladder cancer and glioma cancer, over six randomized Phase II clinical trials and approximately six other investigative clinical trials. The firm focuses on the registration of REOLYSIN in approximately two indications, including the neoadjuvant treatment of muscle-invasive bladder cancer and the treatment of glioblastoma. The firm has conducted a single arm United States Phase II non-small cell lung cancer (NSCLC) trial and a single arm United States Phase II pancreatic cancer trial for REOLYSIN. The firm is also engaged in conducting a Phase Ib trial for REOLYSIN and chemotherapy in combination with pembrolizumab in its Checkpoint Inhibitor Program.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.874 - 2.884 2.884 - 2.893
Low: 2.623 - 2.635 2.635 - 2.646
Close: 2.75 - 2.771 2.771 - 2.787

Technical analysis

as of: 2020-11-29 9:25:51 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 3.35     One year: 3.92
Support: Support1: 2.31    Support2: 1.96
Resistance: Resistance1: 2.87    Resistance2: 3.35
Pivot: 2.24
Moving Average: MA(5): 2.55     MA(20): 2.22
MA(100): 1.95     MA(250): 2.06
MACD: MACD(12,26): 0.13     Signal(9): 0.07
Stochastic oscillator: %K(14,3): 75.70     %D(3): 74.06
RSI: RSI(14): 72.20
52-week: High: 6.02  Low: 0.94  Change(%): 116.4
Average Vol(K): 3-Month: 60611  10-Days: 149173

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ONCY has closed above the upper band by 4.0%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 157.6% wider than normal. The large width of the bands suggest high volatility as compared to ONCY's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Thu, 26 Nov 2020
Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy? - Yahoo Finance

Tue, 24 Nov 2020
Oncolytics Biotech, Inc. (ONCY) Stock Climbs 33.50% This Week; Should You Buy? - InvestorsObserver

Tue, 24 Nov 2020
Oncolytics Biotech Inc. (NASDAQ:ONCY) is Worth a Shot if You’re a Risk-Capital Investor - Marketing Sentinel

Tue, 24 Nov 2020
Oncolytics Biotech Inc. (ONCY) latest performance of 16.89% is not what was on cards - News Daemon

Mon, 23 Nov 2020
Market cap of Oncolytics Biotech Inc. [ONCY] reaches 87.80M – now what? - The DBT News

Mon, 23 Nov 2020
Is Oncolytics Biotech, Inc. (ONCY) a Stock to Watch This Week? - InvestorsObserver

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.